Non-coding nucleotides and amino acids near the active site regulate peptide deformylase expression and inhibitor susceptibility in Chlamydia trachomatis

References

1. Akers J. C., Tan M. ( 2006). Molecular mechanism of tryptophan-dependent transcriptional regulation in Chlamydia trachomatis. J Bacteriol 188:4236–4243 [CrossRef][PubMed]
   [Google Scholar]
2. Amero C. D., Byerly D. W., McElroy C. A., Simmons A., Foster M. P. ( 2009). Ligand-induced changes in the structure and dynamics of Escherichia coli peptide deformylase. Biochemistry 48:7595–7607 [CrossRef][PubMed]
   [Google Scholar]
3. Apfel C., Banner D. W., Bur D., Dietz M., Hirata T., Hubschwerlen C., Locher H., Page M. G., Pirson W. et al. ( 2000). Hydroxamic acid derivatives as potent peptide deformylase inhibitors and antibacterial agents. J Med Chem 43:2324–2331 [CrossRef][PubMed]
   [Google Scholar]
4. Balakrishnan A., Patel B., Sieber S. A., Chen D., Pachikara N., Zhong G., Cravatt B. F., Fan H. ( 2006). Metalloprotease inhibitors GM6001 and TAPI-0 inhibit the obligate intracellular human pathogen Chlamydia trachomatis by targeting peptide deformylase of the bacterium. J Biol Chem 281:16691–16699 [CrossRef][PubMed]
   [Google Scholar]
5. Balakrishnan A., Wang L., Li X., Ohman-Strickland P., Malatesta P., Fan H. ( 2009). Inhibition of chlamydial infection in the genital tract of female mice by topical application of a peptide deformylase inhibitor. Microbiol Res 164:338–346 [CrossRef][PubMed]
   [Google Scholar]
6. Bennett S. ( 2004). Solexa Ltd. Pharmacogenomics 5:433–438 [CrossRef][PubMed]
   [Google Scholar]
7. Caldwell H. D., Kromhout J., Schachter J. ( 1981). Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis. Infect Immun 31:1161–1176[PubMed]
   [Google Scholar]
8. Capecchi M. R. ( 1966). Initiation of E. coli proteins. Proc Natl Acad Sci U S A 55:1517–1524 [CrossRef][PubMed]
   [Google Scholar]
9. Chen H., Tang H., Ebright R. H. ( 2003). Functional interaction between RNA polymerase α subunit C-terminal domain and σ⁷⁰ in UP-element- and activator-dependent transcription. Mol Cell 11:1621–1633 [CrossRef][PubMed]
   [Google Scholar]
10. Datsenko K. A., Wanner B. L. ( 2000). One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A 97:6640–6645 [CrossRef][PubMed]
    [Google Scholar]
11. Dean C. R., Narayan S., Richards J., Daigle D. M., Esterow S., Leeds J. A., Kamp H., Puyang X., Wiedmann B. et al. ( 2007). Reduced susceptibility of Haemophilus influenzae to the peptide deformylase inhibitor LBM415 can result from target protein overexpression due to amplified chromosomal def gene copy number. Antimicrob Agents Chemother 51:1004–1010 [CrossRef][PubMed]
    [Google Scholar]
12. Greene W., Xiao Y., Huang Y., McClarty G., Zhong G. ( 2004). Chlamydia-infected cells continue to undergo mitosis and resist induction of apoptosis. Infect Immun 72:451–460 [CrossRef][PubMed]
    [Google Scholar]
13. Groche D., Becker A., Schlichting I., Kabsch W., Schultz S., Wagner A. F. ( 1998). Isolation and crystallization of functionally competent Escherichia coli peptide deformylase forms containing either iron or nickel in the active site. Biochem Biophys Res Commun 246:342–346 [CrossRef][PubMed]
    [Google Scholar]
14. Guilloteau J. P., Mathieu M., Giglione C., Blanc V., Dupuy A., Chevrier M., Gil P., Famechon A., Meinnel T., Mikol V. ( 2002). The crystal structures of four peptide deformylases bound to the antibiotic actinonin reveal two distinct types: a platform for the structure-based design of antibacterial agents. J Mol Biol 320:951–962 [CrossRef][PubMed]
    [Google Scholar]
15. Haugen S. P., Ross W., Gourse R. L. ( 2008). Advances in bacterial promoter recognition and its control by factors that do not bind DNA. Nat Rev Microbiol 6:507–519 [CrossRef][PubMed]
    [Google Scholar]
16. Hefty P. S., Stephens R. S. ( 2007). Chlamydial type III secretion system is encoded on ten operons preceded by sigma 70-like promoter elements. J Bacteriol 189:198–206 [CrossRef][PubMed]
    [Google Scholar]
17. Koehler J. E., Burgess R. R., Thompson N. E., Stephens R. S. ( 1990). Chlamydia trachomatis RNA polymerase major σ subunit. Sequence and structural comparison of conserved and unique regions with Escherichia coli σ⁷⁰ and Bacillus subtilis σ⁴³. J Biol Chem 265:13206–13214[PubMed]
    [Google Scholar]
18. Mazel D., Pochet S., Marlière P. ( 1994). Genetic characterization of polypeptide deformylase, a distinctive enzyme of eubacterial translation. EMBO J 13:914–923[PubMed]
    [Google Scholar]
19. Moulder J. W. ( 1991). Interaction of chlamydiae and host cells in vitro. Microbiol Rev 55:143–190[PubMed]
    [Google Scholar]
20. Nguyen K. T., Wu J. C., Boylan J. A., Gherardini F. C., Pei D. ( 2007). Zinc is the metal cofactor of Borrelia burgdorferi peptide deformylase. Arch Biochem Biophys 468:217–225 [CrossRef][PubMed]
    [Google Scholar]
21. Oey C. B., Bao X., Lewis C., Kerrigan J. E., Fan H. ( 2011). High tolerance to mutations in a Chlamydia trachomatis peptide deformylase loop. World J Biol Chem 2:90–97 [CrossRef][PubMed]
    [Google Scholar]
22. Rajagopalan P. T. R., Yu X. C., Pei D. ( 1997). Peptide deformylase: a new type of mononuclear iron protein. J Am Chem Soc 119:12418–12419 [CrossRef]
    [Google Scholar]
23. Roshick C., Iliffe-Lee E. R., McClarty G. ( 2000). Cloning and characterization of ribonucleotide reductase from Chlamydia trachomatis. J Biol Chem 275:38111–38119 [CrossRef][PubMed]
    [Google Scholar]
24. Ross W., Aiyar S. E., Salomon J., Gourse R. L. ( 1998). Escherichia coli promoters with UP elements of different strengths: modular structure of bacterial promoters. J Bacteriol 180:5375–5383[PubMed]
    [Google Scholar]
25. Schachter J. ( 1999). Infection and disease epidemiology. Chlamydia Intracellular Biology139–169 Stephens R. S. Washington, DC: American Society for Microbiology;
    [Google Scholar]
26. Schaumburg C. S., Tan M. ( 2003). Mutational analysis of the Chlamydia trachomatis dnaK promoter defines the optimal −35 promoter element. Nucleic Acids Res 31:551–555 [CrossRef][PubMed]
    [Google Scholar]
27. Shen L., Shi Y., Douglas A. L., Hatch T. P., O'Connell C. M., Chen J. M., Zhang Y. X. ( 2000). Identification and characterization of promoters regulating tuf expression in Chlamydia trachomatis serovar F. Arch Biochem Biophys 379:46–56 [CrossRef][PubMed]
    [Google Scholar]
28. Stamm W. E., Handsfield H. H., Rompalo A. M., Ashley R. L., Roberts P. L., Corey L. ( 1988). The association between genital ulcer disease and acquisition of HIV infection in homosexual men. JAMA 260:1429–1433 [CrossRef][PubMed]
    [Google Scholar]
29. Stephens R. S., Kalman S., Lammel C., Fan J., Marathe R., Aravind L., Mitchell W., Olinger L., Tatusov R. L. et al. ( 1998). Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis. Science 282:754–759 [CrossRef][PubMed]
    [Google Scholar]
30. Tan M. ( 2007). Regulation of gene expression. Chlamydia Genomics and Pathogenesis103–131 Bavoil P., Wyrick P. Wymondham, Norfolk, UK: Horizon Bioscience;
    [Google Scholar]
31. Tan M., Engel J. N. ( 1996). Identification of sequences necessary for transcription in vitro from the Chlamydia trachomatis rRNA P1 promoter. J Bacteriol 178:6975–6982[PubMed]
    [Google Scholar]
32. Tan M., Gaal T., Gourse R. L., Engel J. N. ( 1998). Mutational analysis of the Chlamydia trachomatis rRNA P1 promoter defines four regions important for transcription in vitro. J Bacteriol 180:2359–2366[PubMed]
    [Google Scholar]
33. Thomson N. R., Holden M. T. G., Carder C., Lennard N., Lockey S. J., Marsh P., Skipp P., O'Connor C. D., Goodhead I. et al. ( 2008). Chlamydia trachomatis: genome sequence analysis of lymphogranuloma venereum isolates. Genome Res 18:161–171 [CrossRef][PubMed]
    [Google Scholar]
34. Twist K. A., Husnain S. I., Franke J. D., Jain D., Campbell E. A., Nickels B. E., Thomas M. S., Darst S. A., Westblade L. F. ( 2011). A novel method for the production of in vivo-assembled, recombinant Escherichia coli RNA polymerase lacking the α C-terminal domain. Protein Sci 20:986–995 [CrossRef][PubMed]
    [Google Scholar]
35. Wise R., Andrews J. M., Ashby J. ( 2002). In vitro activities of peptide deformylase inhibitors against Gram-positive pathogens. Antimicrob Agents Chemother 46:1117–1118 [CrossRef][PubMed]
    [Google Scholar]
36. Xiao Y., Zhong Y., Greene W., Dong F., Zhong G. ( 2004). Chlamydia trachomatis infection inhibits both Bax and Bak activation induced by staurosporine. Infect Immun 72:5470–5474 [CrossRef][PubMed]
    [Google Scholar]
37. Yu H. H., Di Russo E. G., Rounds M. A., Tan M. ( 2006). Mutational analysis of the promoter recognized by Chlamydia and Escherichia coli σ²⁸ RNA polymerase. J Bacteriol 188:5524–5531 [CrossRef][PubMed]
    [Google Scholar]